Phytalgic promotes knee pain reliefPhytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.
High relevance for osteoarthritis treatment
We evaluated the effectiveness of Phytalgic, a supplement containing fish oil, on reducing knee pain in patients with osteoarthritis. In a randomized double-blind study of 81 participants, those taking Phytalgic reported lower usage of analgesics and NSAIDs compared to the placebo group.
Our findings showed significant reductions in pain, stiffness, and overall knee function, highlighting the potential benefit of Phytalgic in managing osteoarthritis symptoms. Overall, it seems that Phytalgic may offer an alternative relief option for those suffering from knee pain.
Read More
DHA reduces knee pain and swellingChronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of Complete Freund's Adjuvant-induced knee arthritis.
Animal model study results
We explored whether purified docosahexaenoic acid (DHA), an omega-3 fatty acid, can ease knee pain and swelling in a mouse model of arthritis. Mice with arthritis were treated with either oral or injected DHA, and we observed notable improvements in pain behavior and knee swelling.
This study highlights that DHA may reduce pain and inflammation in knee arthritis, suggesting it could be a helpful option for those suffering from rheumatoid arthritis. However, it’s essential to keep in mind that these results come from an animal model, and human studies are necessary.
Read More
Eicosapentaenoic Acid Reduces Knee PainEfficacy of Extract and/or an Omega-3-Based Product for Improving Pain and Function in People Older Than 40 Years with Persistent Knee Pain: A Randomized Double-Blind Controlled Clinical Trial.
Study explores combined supplement effects
We conducted a study to investigate how eicosapentaenoic acid (EPA), a component of omega-3 fatty acids, impacts knee pain in healthy adults over the age of 40 with persistent discomfort. The study was structured as a randomized, double-blind, controlled clinical trial, which means that participants were assigned to either an EPA product or a placebo without knowing which they were receiving.
Over eight weeks, we observed four different groups: those taking pure EPA, those on a blend of EPA and another supplement, those on just the other supplement, and a placebo group. Our findings revealed that participants who consumed the EPA-based product experienced significant reductions in pain as measured by a visual analog scale (VAS), with the most noticeable improvements at the end of the eight weeks.
Additionally, the use of EPA seemed to enhance the quality of life by improving overall function and even aiding in better sleep quality. We also noted that the time taken to complete mobility tasks improved after the use of the EPA product. All participants reported safety, making EPA an appealing option for managing knee pain.
However, it’s important to note that the study included a combination of supplements, making it difficult to isolate the specific effects of just the eicosapentaenoic acid. Despite this, we feel confident in stating that incorporating EPA could be beneficial for those struggling with knee pain.
Read More
We conducted a comprehensive study involving 177 patients with moderate to severe osteoarthritis (OA) affecting their hips or knees. Over 26 weeks, participants were divided into two groups. One group received glucosamine sulfate combined with omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The other group was treated with glucosamine sulfate alone.
Our main focus was to determine whether the combined treatment provided any notable benefits over glucosamine alone when it came to easing knee pain. We used the WOMAC score to assess pain, stiffness, and overall function in the participants. When we looked at the significant reduction of pain, more than 92% from both groups experienced some relief, but the combination treatment showed a higher response rate of 44%, compared to 32% in the glucosamine-only group.
Although both treatments appeared safe over the study duration, the statistical differences indicate that adding omega-3s can be beneficial for those specifically hoping for greater relief. We also noted that symptoms like morning stiffness and knee pain showed improvements, with greater reductions in the group taking the combination treatment. This suggests that eicosapentaenoic acid may provide added value in managing knee pain due to osteoarthritis, particularly for patients looking to maximize their treatment benefits.
Read More
Omega-3 reduces knee pain effectivelyEfficacy of Extract and/or an Omega-3-Based Product for Improving Pain and Function in People Older Than 40 Years with Persistent Knee Pain: A Randomized Double-Blind Controlled Clinical Trial.
High relevance for older adults
We conducted a rigorous clinical trial to investigate how omega-3 fish oil affects knee pain in people aged 40 and older. In this double-blind study with four groups, we found that those taking an omega-3-based product, AvailOm, experienced a notable reduction in pain intensity compared to a placebo.
By week eight, participants reported less discomfort and improved quality of life. Additionally, the intake of AvailOm led to better muscle strength and sleep quality, making it a promising option for alleviating persistent knee pain. Overall, omega-3 fish oil shows effective benefits for older adults struggling with knee pain.
Read More